Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design
Lietman, P.; Temple, R.; Harrington, M.; Peck, C.
Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
1990
ISSN/ISBN: 0894-9255 PMID: 2231299 Document Number: 355726
Document emailed within 1 workday
Related Documents
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88Overall, J.E. 1989: Design issues in clinical trials Progress in Clinical and Biological Research 317: 1291-1299
Fleming, T.R. 1999: Issues in the design of clinical trials: insights from the trastuzumab (Herceptin) experience Seminars in Oncology 26(4 Suppl. 12): 102-107
DeMets, D.L. 1990: Methodological issues in AIDS clinical trials. Data monitoring and sequential analysis--an academic perspective Journal of Acquired Immune Deficiency Syndromes 3(Suppl 2): S124-S133
Feigal, E.G.; Phillips, P.H.; Cheson, B.D. 1997: Clinical Trials Referral Resource. Clinical trials in AIDS related malignancies Oncology 11(3): 337-338; 341
Gibson, R.S.; Sazawal, S.; Peerson, J.M. 2003: Design and quality control issues related to dietary assessment, randomized clinical trials and meta-analysis of field-based studies in developing countries Journal of Nutrition 133(5 Suppl 1): 1569s-1573s
Antczak-Bouckoms, A.; Chalmers, T.C. 1988: The importance of design and analysis in clinical trials Journal of Oral Implantology 14(1): 36-42
Prasad, V.K. 2019: Improving the design of pivotal clinical trials Clinical Advances in Hematology and Oncology: H&o 17(3): 150-152
Lusher, J.M. 1984: Assessment of response to treatment and design of clinical trials Progress in Clinical and Biological Research 150: 167-179
Gehan, E.A. 1982: Design of controlled clinical trials: use of historical controls Cancer Treatment Reports 66(5): 1089-1093
Dellinger, E.P. 1991: Design and evaluation of clinical trials of antimicrobial agents in surgery Surgery Gynecology and Obstetrics 172 Suppl: 65-72
Neidert, G.L. 1982: Design and interpretation of clinical trials of long-acting analgesics PharmacoTherapy 2(5): 285-286
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Weigmann, K. 2015: The ethics of global clinical trials: in developing countries, participation in clinical trials is sometimes the only way to access medical treatment. what should be done to avoid exploitation of disadvantaged populations? Embo Reports 16(5): 566-570